It has repeatedly been shown that the use of G-CSF reduces the risk of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) and considerably shorten the hospitalizations of patients [2,3]. Here, CSF3 is linked to Decreased total neutrophil count.